Ziphius Vaccines
Supplier & provider
Ziphius Vaccines
Description
Ziphius is developing proprietary self-amplifying mRNA technologies combined with innovative lipid formulations for targeted delivery. This allows us to generate a broad pipeline of late pre-clinical and early clinical stage products, including prophylactic vaccines against infectious diseases and gene supplementation therapies for the treatment of rare genetic disorders.
Ziphius Vaccines
Address
Heidestraat 19,
9820 Merelbeke, BELGIUM
9820 Merelbeke, BELGIUM
Contact
info@ziphius.org
Description
Ziphius is developing proprietary self-amplifying mRNA technologies combined with innovative lipid formulations for targeted delivery. This allows us to generate a broad pipeline of late pre-clinical and early clinical stage products, including prophylactic vaccines against infectious diseases and gene supplementation therapies for the treatment of rare genetic disorders.
Matchmaking
Connect with Ziphius Vaccines
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways